Company intelligence / Profile preview

DSD Pharma

Purkersdorf, Niederösterreich, Austriadsd-pharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

DSD Pharma is a GDP-certified distributor specializing in pharmaceuticals, radiopharmaceuticals, and medical products for nuclear medicine. The company offers a broad portfolio of diagnostic and therapeutic solutions including radiopharmaceuticals for PET, SPECT, and scintigraphy. Through partnerships such as with Isotopia for Isoprotrace®, it provides advanced imaging agents like Gallium (68Ga) Gozetotide for prostate cancer diagnosis in Germany.[1][3][4][5]

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalsPeptidesMedical DevicesLabelling Kits for PET, SPECT, Scintigraphy[1][3][4]
Industry: Medical Imaging

Drug pipeline

1 asset

Isoprotrace

Commercial

Indications: Prostate cancer imaging

Partnerships

Isotopia – exclusive distribution of Isoprotrace® in Germany[5]

Beyond the preview

Go deeper on DSD Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSD Pharma.

Explore the full profile